77 related articles for article (PubMed ID: 3986814)
1. Increased mutation frequency following treatment with cancer chemotherapy.
Dempsey JL; Seshadri RS; Morley AA
Cancer Res; 1985 Jun; 45(6):2873-7. PubMed ID: 3986814
[TBL] [Abstract][Full Text] [Related]
2. Second neoplasms following radiotherapy or chemotherapy for cancer.
Penn I
Am J Clin Oncol; 1982 Feb; 5(1):83-96. PubMed ID: 7081142
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of HPRT mutant frequency in children with cancer.
Rice SC; Vacek PM; Homans AH; Kendall H; Rivers J; Messier T; Finette BA
Environ Mol Mutagen; 2003; 42(1):44-9. PubMed ID: 12874812
[TBL] [Abstract][Full Text] [Related]
4. Mutation frequency and spectrum in lymphocytes of small cell lung cancer patients receiving etoposide chemotherapy.
Karnaoukhova L; Moffat J; Martins H; Glickman B
Cancer Res; 1997 Oct; 57(19):4393-407. PubMed ID: 9331103
[TBL] [Abstract][Full Text] [Related]
5. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
Glanzmann C; Veraguth A; Lütolf UM
Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
[TBL] [Abstract][Full Text] [Related]
6. Pycnogenol may alleviate adverse effects in oncologic treatment.
Belcaro G; Cesarone MR; Genovesi D; Ledda A; Vinciguerra G; Ricci A; Pellegrini L; Gizzi G; Ippolito E; Dugall M; Cacchio M; Di Renzo A; Stuard S
Panminerva Med; 2008 Sep; 50(3):227-34. PubMed ID: 18927527
[TBL] [Abstract][Full Text] [Related]
7. Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy.
Bokstein F; Lossos A; Siegal T
Cancer; 1998 May; 82(9):1756-63. PubMed ID: 9576299
[TBL] [Abstract][Full Text] [Related]
8. Acute and long-term cytogenetic effects of childhood cancer chemotherapy and radiotherapy.
Miller RC; Hill RB; Nichols WW; Meadows AT
Cancer Res; 1978 Oct; 38(10):3241-6. PubMed ID: 210931
[TBL] [Abstract][Full Text] [Related]
9. Sister chromatid exchange studies for monitoring DNA damage in lymphocytes of malignant lymphoma patients under cytostatic therapy.
Sardaş S; Erdoğan F; Sardaş OS; Cengel M; Karakaya AE
Anticancer Drugs; 1994 Aug; 5(4):487-9. PubMed ID: 7524801
[TBL] [Abstract][Full Text] [Related]
10. [Cytoprotection with amifostine in radiotherapy or radio-chemotherapy of head and neck tumors].
Altmann S; Hoffmanns H
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():30-3. PubMed ID: 10584138
[TBL] [Abstract][Full Text] [Related]
11. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
[TBL] [Abstract][Full Text] [Related]
12. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
13. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer.
Hooning MJ; Aleman BM; Hauptmann M; Baaijens MH; Klijn JG; Noyon R; Stovall M; van Leeuwen FE
J Clin Oncol; 2008 Dec; 26(34):5561-8. PubMed ID: 18854572
[TBL] [Abstract][Full Text] [Related]
14. Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma.
Greene MH; Young RC; Merrill JM; DeVita VT
Cancer Res; 1983 Apr; 43(4):1891-8. PubMed ID: 6572558
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of cancer therapy. Risk of secondary neoplasms.
Coleman CN
Am J Pediatr Hematol Oncol; 1982; 4(1):103-11. PubMed ID: 7091571
[TBL] [Abstract][Full Text] [Related]
16. [The function of the immune system after the treatment of pediatric malignant diseases].
Gadó J; Schlick B; Bárány O; Németh J; Müller J; Csóka M; Constantin T; Vonnák E; Böcskei R; Hauser P; Kovács G
Orv Hetil; 2006 Sep; 147(36):1731-8. PubMed ID: 17087017
[TBL] [Abstract][Full Text] [Related]
17. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
18. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
19. Second primary cancer due to radiotherapy and chemotherapy.
Manavoğlu O; Orhan B; Evrensel T; Karabulut Y; Ozkocaman V; Ozyardimci C
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):275-8. PubMed ID: 9216821
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
Nowrousian MR
Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
